Personalized cancer vaccines vanquish melanoma in small but encouraging study

Main|Search|PHGKB




Last Posted: Jul 06, 2017

---

• Personalized cancer vaccines vanquish melanoma in small but encouraging study  
  S Begley, StatNews, July 5, 2017
• Implementation and utilization of the molecular tumor board to guide precision medicine.  
  Harada Shuko et al. Oncotarget 2017 Jun
• Does personalised melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?  
  Smit A K et al. The British journal of dermatology 2017 Jun
• Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.  
  Farberg Aaron S et al. Journal of drugs in dermatology : JDD 2017 May 16(5) 428-431
• PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.  
  Schultz Kris Ann P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jun 23(12) e76-e82
• Critical role of RIG-I and MDA5 in early and late stages of Tulane virus infection.  
  Chhabra Preeti et al. The Journal of general virology 2017 May 98(5) 1016-1026
• Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar.  
  Wu Yelena P et al. Journal of genetic counseling 2017 May
• Identification, genetic testing, and management of hereditary melanoma.  
  Leachman Sancy A et al. Cancer metastasis reviews 2017 Mar 36(1) 77-90
• Whole-genome landscapes of major melanoma subtypes  
  NK Hayward et al, Nature, May 3, 2017
• StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.  
  Sen Manimala et al. Cancer medicine 2017 Apr
• Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.  
  de Unamuno Bustos Blanca et al. Scientific reports 2017 Mar 7(1) 495
• Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.  
  et al. JAMA oncology 2017 Feb
• Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.  
  Zheng Gang et al. American journal of clinical pathology 2016 May 145(5) 696-702
• Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.  
  Kohn Christine G et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Feb JCO2016696336
• Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.  
  Hamblin Angela et al. PLoS medicine 2017 Feb 14(2) e1002230
• Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.  
  Paasinen-Sohns Aino et al. Neoplasia (New York, N.Y.) 2017 Feb 19(3) 196-206

more